Featured News

We put together a list of some of the most common perceived barriers to participating in clinical trials, and how to overcome them.

Cour Pharmaceuticals has announced a $420 million licensing deal with Takeda Pharmaceuticals following a favorable outcome of their phase 2 trial for celiac disease. The company released data from a small phase 2a study at the annual United European Gastroenterology organization meeting showing that its treatment, CNP-101, cut levels of inflammation-promoting cytokines. The technology was…

Parents using multiple kitchen appliances and utensils to prevent their child with celiac disease from being exposed to gluten may be able to eliminate some cumbersome steps. A new, preliminary study from Children’s National Hospital published in the journal Gastroenterology found no significant gluten transfer when tools like the same toaster or knives are used for both…

CEO Marilyn G. Geller’s testimony before the House Appropriations Subcommittee has helped secure report language in the House’s version of the 2020 Labor-HHS-Education bill demanding that the National Institute of Health (NIH) report to Congress in 90 days on its plans to aid celiac disease patients. This acknowledgment that celiac disease is a serious condition…

Researchers found that children with celiac disease have a 1.2-1.8 higher risk of psychological conditions such as depression, mood disorders, behavioral problems, ADHD, eating disorders, autism, and other intellectual disabilities.

CEO Marilyn G. Geller speaks at the 18th International Celiac Disease Symposium (ICDS).

ActoBio announces FDA has given permission to an Investigational New Drug (IND) application for Actobiotics® AG017, a therapeutic candidate for celiac disease.

Often, when a patient is following a long-term gluten-free diet with good compliance, micronutrient deficiencies cannot be detected. This review - published in the scientific journal Medicina - evaluates the most recent literature on micronutrient deficiencies in patients following a long-term gluten-free diet in order to provide dietary supplementation advice. The study concludes that in patients with micronutrient deficiencies caused by celiac disease, vitamin supplements may be necessary.

A study published by the Journal of the American Medical Association (JAMA) concluded that higher gluten intake during the first 5 years of life is correlated with an increased risk of celiac disease among children who possess the HLA genes associated with celiac disease. The study was conducted in research centers in the United States, Finland, Germany, and Sweden.

The Celiac Disease Foundation was proud to be an endorsement partner of the 2019 James W. Freston Conference – Food at the Intersection of Gut Health and Disease to educate physicians on the latest research on celiac disease management. On August 9-10, 2019, Director of Research and Advocacy, Julia McBeth, attended the conference in Chicago,…